Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker(Herlev Hospital), Hakan Kültürsay, S.D. Anker, Tamás Forster(Brigham and Women's Hospital), Juey‐Jen Hwang, Hiroaki Shimokawa(Tohoku University), Patrick Commerford, Marc Y. Donath(University of Basel), Jan H. Cornel(Brigham and Women's Hospital), Hisao Ogawa(Kumamoto University Hospital), Petar Otašević, Alessandro Fucili, Jacques Genest(McGill University Health Centre), Ki‐Bae Seung, Wolfgang Köenig(German Centre for Cardiovascular Research), Francisco Antônio Helfenstein Fonseca(Universidade Federal de São Paulo), George Varigos, Peter Sinnaeve(Brigham and Women's Hospital), Jean MacFadyen(Brigham and Women's Hospital), Peter Siostrzonek(Unknown), Irina Veze, Mitja Lainščak, Félix Medina, Renata Cífková(Brigham and Women's Hospital), Alberto Lorenzatti(Brigham and Women's Hospital), Nina Gotcheva, L Vida-Simiti(Brigham and Women's Hospital), Birutė Petrauskienė, John J.P. Kastelein(QRx Pharma (United States)), Tor Ole Klemsdal, Zhanna Kobalava(Peoples' Friendship University of Russia), Yong Huo(Sun Yat-sen University), Davor Miličić, Leon Salvador, Miguel Urina‐Triana, Axel F. Sigurðsson, Tom Thurén(Novartis (Switzerland)), Daniel Pella(Brigham and Women's Hospital), Athanasios Manolis, Henry Krum(Australian Regenerative Medicine Institute), Mikael Dellborg(Brigham and Women's Hospital), Fernando Wyss, Prem Pais(Brigham and Women's Hospital), Peter Libby(Brigham and Women's Hospital), Robert J. Glynn(Brigham and Women's Hospital), José Carlos Nicolau(Hospital São Paulo), Riina Vettus, Andrzej Budaj
Cited by 1,306
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k